The DayOne Accelerator has helped launch more than 40 innovative healthtech ventures since we started operating in 2018. You can find details of all our active alumni companies below.
Portfolio
In the spotlight
Portfolio
Company
Therapeutic areas
Country
Funding Stage
Development stage
machineMD
Therapeutic area: Neurology, Ophtalmology
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
Neurology, Ophtalmology
Switzerland
Serie A
Commercial launch
Magnes
Therapeutic area: Neurology, Preventive Health, Rehabilitation
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
Neurology, Preventive Health, Rehabilitation
Switzerland
Serie A
Commercial launch
MicroX Labs
Therapeutic area: Chronic diseases, Hematology, Infectious diseases
Country: United States
Funding Stage: Serie A
Development stage: Design & development
Chronic diseases, Hematology, Infectious diseases
United States
Serie A
Design & development
MiiCare
Therapeutic area: Chronic diseases, Geriatrics, Preventive Health
Country: United Kingdom
Funding Stage: Serie A
Development stage: Commercial launch
Chronic diseases, Geriatrics, Preventive Health
United Kingdom
Serie A
Commercial launch
noul
Therapeutic area: Infectious diseases, Oncology
Country: South Korea
Funding Stage: Serie C+
Development stage: Commercial launch
Infectious diseases, Oncology
South Korea
Serie C+
Commercial launch
Nutrix
Therapeutic area: Chronic diseases, Mental Health, Preventive Health
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
Chronic diseases, Mental Health, Preventive Health
Switzerland
Serie A
Commercial launch
OncoDecipher
Therapeutic area: Oncology
Country: Israel
Funding Stage: Seed
Development stage: Preclinical research & prototyping
Oncology
Israel
Seed
Preclinical research & prototyping
Oncoustics
Therapeutic area: Gastroenterology, Metabolic Diseases, Nephrology
Country: Canada
Funding Stage: Seed
Development stage: Design & development
Gastroenterology, Metabolic Diseases, Nephrology
Canada
Seed
Design & development
OptiChroniX
Therapeutic area: Brain Health, Chronic diseases, Geriatrics, Preventive Health
Country: Switzerland
Funding Stage: Pre seed
Development stage: Preclinical research & prototyping
Brain Health, Chronic diseases, Geriatrics, Preventive Health
Switzerland
Pre seed
Preclinical research & prototyping
Presentient Technologies
Therapeutic area: z-Other
Country: United Kingdom
Funding Stage: Seed
Development stage: Design & development
z-Other
United Kingdom
Seed
Design & development